Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.
about
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cellsThe cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells
P2860
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cholesterol biosynthesis inhib ...... cyclase inhibitor RO 48-8071.
@en
type
label
Cholesterol biosynthesis inhib ...... cyclase inhibitor RO 48-8071.
@en
prefLabel
Cholesterol biosynthesis inhib ...... cyclase inhibitor RO 48-8071.
@en
P2093
P2860
P1476
Cholesterol biosynthesis inhib ...... cyclase inhibitor RO 48-8071.
@en
P2093
Benford Mafuvadze
Cynthia Besch-Williford
Johannes D Aebi
Matthew T Cook
Salman M Hyder
Xiaoqin Zou
Yayun Liang
P2860
P2888
P356
10.1007/S10549-014-2996-5
P407
P577
2014-05-31T00:00:00Z
P6179
1020578434